Table 3.
Results of meta-analysis for MMP-2-1306 C/T polymorphism and bladder cancer risk
Comparison | Test of association | Model | Test of heterogeneity | |||
---|---|---|---|---|---|---|
OR | 95 % CI | P | P | I 2 | ||
T vs. C | 1.13 | 0.71–1.81 | 0.599 | R | 0.001 | 86.4 |
TT vs. CC | 2.10 | 1.38–3.10 | 0 | F | 0.251 | 27.8 |
TC vs. CC | 1.12 | 0.64–1.95 | 0.698 | R | 0 | 90.6 |
TT vs. TC/CC | 1.42 | 0.93–2.16 | 0.110 | F | 0.669 | 0 |
TT/TC vs. CC | 1.11 | 0.68–1.83 | 0.679 | R | 0 | 90.1 |
OR odds ratio, CI confidence interval, F fixed effect model, R random effect model